NCT04296123

Brief Summary

Abstract: Objectives: (i) To investigate the test-retest and inter-rater reliability, construct and known-group validity of four independent step tests in older adults with mild to moderate dementia (Phase 1); and (ii) the feasibility and effects of a 12-week step training on the step performance, physical and functional outcomes in this population (Phase 2). Design and subjects: Older adults who have mild to moderate dementia, and able to walk independently without walking aids, with stick or quadripod will be recruited to participate in this study. Participants will perform four step tests, including Four Square Step Test (FSST), Choice Stepping Reaction Time Test (CSRTT), Maximum Step Length Test (MSLT) and Alternate Step Test (AST) on three separate testing occasions conducted by two independent raters at the baseline (Phase 1). The participants will then join either an intervention or control group. Those in the intervention group will receive a 12-week step training, while the control group will receive usual care. The stepping performance using the step tests validated in Phase 1, cognitive and functional outcomes and prospective falls will be compared between the intervention and control groups at 12 and 24 weeks (Phase 2). Interventions: The step training consists of two 30-minute training sessions per week. The participants will receive an individualized, progressive training that is tailored to their stepping ability and cognitive function. Main outcome measures: Stepping performance using the four step tests, 2-minute walk test, 10-meter walk test, 30-second sit to stand test, Berg Balance Scale, Montreal Cognitive Assessment and prospective falls at 12 and 24 weeks. Expected results: (i) The four step tests are reliable in older adults with mild to moderate dementia, and the findings of the step tests are moderately associated with the functional outcomes, and (ii) the participants in the intervention group will have better stepping performance, better functional outcomes and fewer falls compared with the control group at 12 weeks, and the effects will sustain at 24 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

October 4, 2024

Status Verified

October 1, 2024

Enrollment Period

4.2 years

First QC Date

March 2, 2020

Last Update Submit

October 2, 2024

Conditions

Outcome Measures

Primary Outcomes (8)

  • Four Square Step Test

    12 weeks

  • Four Square Step Test

    24 weeks

  • Choice Stepping Reaction Time Test

    12 weeks

  • Choice Stepping Reaction Time Test

    24 weeks

  • Maximum Step Length Test

    12 weeks

  • Maximum Step Length Test

    24 weeks

  • Alternate Step Test

    12 weeks

  • Alternate Step Test

    24 weeks

Secondary Outcomes (6)

  • 10-meter walk test

    0, 12 and 24 weeks

  • 2-minute walk test

    0, 12 and 24 weeks

  • 30-second sit to stand test

    0, 12 and 24 weeks

  • Berg balance scale

    0, 12 and 24 weeks

  • Number of falls

    0, 12 and 24 weeks

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL
Behavioral: Step training

Control

NO INTERVENTION

Interventions

Step trainingBEHAVIORAL

A 12-week step training consisting of two 30-minute training session per week. The participants will be instructed to stand upright and step on different targets on a plastic mat repeatedly.

Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years or above
  • able to walk independently without walking aid, with stick or quadripod
  • clinical diagnosis of dementia

You may not qualify if:

  • unstable cardiac or pulmonary conditions
  • acute musculoskeletal or severe neurological conditions affecting stepping performances
  • severe hearing or visual impairment limiting communication
  • severe cognitive impairment
  • recent hospitalization in the past 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

Related Publications (1)

  • Chan WLS, Tsang SMH, Ho LYW. Reliability and Validity of Four Step Tests in Older Adults With Dementia. Int J Geriatr Psychiatry. 2024 Dec;39(12):e70021. doi: 10.1002/gps.70021.

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Wayne Chan, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 2, 2020

First Posted

March 5, 2020

Study Start

January 1, 2020

Primary Completion

March 31, 2024

Study Completion

March 31, 2024

Last Updated

October 4, 2024

Record last verified: 2024-10

Locations